EVGN

Evogene Ltd

0.3642

Oct 22 • 8:00 AM ET -0.0062 (-1.67%)

Healthcare Biotechnology Israel Nano NASD

Peers: CBUS MLEC DNA DYAI CDXS CLGN RXRX ABSI EXOZ LNAI

Index	-
Market Cap	5.75M
Enterprise Value	7.56M
Income	-9.07M
Sales	1.31M
Book/sh	-0.24
Cash/sh	0.59
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	52
IPO	Mar 05, 2008

P/E	-
Forward P/E	-
PEG	-
P/S	4.39
P/B	-
P/C	0.62
P/FCF	-
EV/EBITDA	-
EV/Sales	5.77
Quick Ratio	3.54
Current Ratio	3.57
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-0.91
EPS next Y	-0.60
EPS next Q	-0.19
EPS this Y	-2.08%
EPS next Y	45.45%
EPS next 5Y	25.25%
EPS past 3/5Y	44.96% 33.52%
Sales past 3/5Y	32.01% 29.94%
EPS Y/Y TTM	59.44%
Sales Y/Y TTM	-80.59%
EPS Q/Q	76.53%
Sales Q/Q	-60.75%
Earnings	Aug 18 BMO
EPS/Sales Surpr.	48.15% 6.77%

Insider Own	36.98%
Insider Trans	27.53%
Inst Own	2.30%
Inst Trans	4.50%
ROA	-71.03%
ROE	-
ROIC	-
Gross Margin	-14.15%
Oper. Margin	-1019.82%
Profit Margin	-694.19%
SMA20	-7.78%
SMA50	-23.36%
SMA200	-46.85%
Trades

Shs Outstand	13.54M
Shs Float	9.96M
Short Float	9.36%
Short Ratio	0.66
Short Interest	0.93M
52W High	1.33 -72.62%
52W Low	0.35 5.50%
Volatility	7.15% 12.11%
ATR (14)	0.04
RSI (14)	36.69
Beta	1.46
Rel Volume	0.04
Avg Volume	1.41M
Volume	2,531

Perf Week	-8.93%
Perf Month	-19.48%
Perf Quarter	-32.87%
Perf Half Y	-53.65%
Perf YTD	-66.89%
Perf Year	-71.32%
Perf 3Y	-92.25%
Perf 5Y	-98.65%
Perf 10Y	-99.40%
Recom	1.00
Target Price	2.15
Prev Close	0.37
Price	0.36
Change %	-1.67%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-08-21	Initiated	ROTH Capital	Buy	$7
Jul-29-21	Initiated	Aegis Capital	Buy	$10
Dec-01-20	Initiated	Cantor Fitzgerald	Overweight	$9
Dec-16-13	Initiated	Oppenheimer	Outperform	$26

Oct-20-26 08:00AM	Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL (PR Newswire)
Oct-06-26 04:00PM	Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors (PR Newswire)
Sep-30-26 07:15AM	Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance (PR Newswire)
Aug-31-26 08:00AM	Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward (PR Newswire)
Aug-25-26 07:00AM	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees (PR Newswire)
08:30AM	Loading…
Aug-19-26 08:30AM	Evogene Ltd. Q2 2026 Earnings Call Summary (Moby)
Aug-18-26 05:01PM	Evogene Ltd (EVGN) (Q2 2026) Earnings Call Highlights: Strategic Pivot to AI-Driven Drug ... (GuruFocus.com)
08:04AM	Evogene Reports Second Quarter and First Half 2026 Financial Results (PR Newswire)
07:13AM	Evogene: Q2 Earnings Snapshot (Associated Press)
Aug-17-26 05:50PM	Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth Quarterly Update Report (Exec Edge) -6.79%
09:17AM	Earnings To Watch: Evogene Ltd (EVGN) Q2 2026 -- GF Value Sees 15% Downside (GuruFocus.com)
Aug-14-26 07:00AM	Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation (PR Newswire) -7.71%
Jul-30-26 07:00AM	Evogene Schedules Second Quarter 2026 Financial Results Release (PR Newswire)
Jul-23-26 06:06AM	Evogene and ELEO to develop new oral PCSK9 inhibitors (Pharmaceutical Technology)
Jul-22-26 08:00AM	Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases (PR Newswire)
04:31PM	Loading…
Jul-21-26 04:31PM	Cibus Incs Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection (Exec Edge)
04:27PM	Cibus Incs Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection Downloadable Initiation Report (Exec Edge)
Jul-15-26 07:30AM	AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag Capabilities (PR Newswire) +19.95%
Jul-09-26 06:35AM	Evogene and Tel Aviv University launch drug discovery initiative (Pharmaceutical Business Review) +20.74%
Jul-08-26 07:00AM	Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery (PR Newswire)
Jun-24-26 08:00AM	Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI Toward Autonomous Small Molecule Discovery and Optimization (PR Newswire) -10.55%
Jun-09-26 07:00AM	Evogene to Present Its Pharma Division Achievements at the BIO International Convention (PR Newswire)
Jun-02-26 07:00AM	Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica (PR Newswire) -13.60%
May-28-26 09:00PM	Evogene Ltd (EVGN) Q1 2026 Earnings Call Highlights: Strategic Collaborations Amid Financial ... (GuruFocus.com)
May-20-26 12:43PM	Evogene Ltd. Q1 2026 Earnings Call Summary (Moby)
09:59AM	Evogene Shares Decline After Revenue Miss Despite Stronger-Than-Expected Earnings (EVGN) (InvestorsHub)
07:06AM	Evogene: Q1 Earnings Snapshot (Associated Press)
07:00AM	Evogene Reports First Quarter 2026 Financial Results (PR Newswire)
May-12-26 08:00AM	Evogene to Present at the 24th Schrodinger European User Group Meeting (PR Newswire)
May-07-26 08:00AM	Evogene Schedules First Quarter 2026 Financial Results Release (PR Newswire)
04:01PM	Loading…
Apr-02-26 04:01PM	Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification (PR Newswire)
Mar-31-26 08:00AM	Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock (PR Newswire)
Mar-13-26 09:01PM	Evogene Ltd (EVGN) Q4 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Decline (GuruFocus.com)
Mar-09-26 09:00AM	Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026 (PR Newswire)
Mar-06-26 08:30AM	Evogene Ltd. Q4 2025 Earnings Call Summary (Moby)
Mar-05-26 07:32AM	Evogene: Q4 Earnings Snapshot (Associated Press Finance) -6.16%
07:00AM	Evogene Reports Fourth Quarter and Full Year 2025 Financial Results (PR Newswire)
Feb-25-26 08:00AM	Evogene Releases CEO Letter to Shareholders (PR Newswire)
Feb-19-26 08:00AM	Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release (PR Newswire) -5.57%
Feb-18-26 06:17AM	Evogene and QUT partner on AI-based cancer therapies (Pharmaceutical Business Review)
Feb-17-26 08:00AM	Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics (PR Newswire)
Feb-11-26 08:00AM	Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases (PR Newswire)
Feb-10-26 01:20PM	Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds (PR Newswire) -7.34%
08:00AM	Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI (PR Newswire)
Feb-09-26 08:00AM	Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board (PR Newswire)
Feb-04-26 08:00AM	Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer (PR Newswire)
Jan-07-26 07:00AM	Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders (PR Newswire)
Dec-30-25 07:00AM	Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development (PR Newswire)
Nov-20-25 07:00AM	Evogene Reports Third Quarter 2025 Financial Results (PR Newswire) -7.69%
Nov-11-25 07:00AM	Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming (PR Newswire)
Nov-06-25 09:00AM	Evogene Schedules Third Quarter 2025 Financial Results Release (PR Newswire)
Aug-28-25 07:00AM	Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York (PR Newswire)
Aug-20-25 03:05AM	Evogene Ltd (EVGN) Q2 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts Amid ... (GuruFocus.com)
Aug-19-25 07:10AM	Evogene: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Evogene Reports Second Quarter 2025 Financial Results (PR Newswire)
Aug-12-25 07:00AM	Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases (PR Newswire)
Jul-29-25 07:00AM	Evogene Schedules Second Quarter 2025 Financial Results Release (PR Newswire)
Jul-08-25 07:00AM	Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL (PR Newswire) +6.82%
Jun-10-25 07:00AM	Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud (PR Newswire) +100.00%
May-22-25 01:21AM	EverGen Infrastructure Corp. Announces Closing of First Tranche of Private Placement and Change of Management (GlobeNewswire)
May-21-25 07:00AM	Evogene Reports First Quarter 2025 Financial Results (PR Newswire) -6.69%
May-14-25 08:37PM	EverGen Infrastructure Corp. Announces Receipt of TSX Venture Exchange Final Approval of Real Property Sale and Update to Previously Announced Financing (GlobeNewswire)
May-08-25 07:00AM	Evogene Schedules First Quarter 2025 Financial Results Release (PR Newswire)
Apr-22-25 09:24AM	Why Evogene Ltd. (EVGN) Soared on Monday (Insider Monkey) -11.81%
Apr-21-25 07:00AM	ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio (PR Newswire) +30.93%
Mar-06-25 07:15AM	Evogene Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
07:00AM	Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 (PR Newswire)
Feb-20-25 07:00AM	Evogene Schedules Fourth Quarter 2024 Financial Results Release (PR Newswire) -5.60%
Feb-13-25 08:00AM	AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease (PR Newswire)
Nov-21-24 07:30AM	Evogene Reports Third Quarter 2024 Financial Results (PR Newswire)
Nov-19-24 07:00AM	Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results (PR Newswire)
Nov-12-24 07:00AM	Lavie Bio Announces Commercial Expansion of Yalos as Seed-Treatment for Soybean, Following Successful Field Trials (PR Newswire)
Nov-07-24 07:00AM	Evogene Schedules Third Quarter 2024 Financial Results Release (PR Newswire) -6.74%
Oct-31-24 08:00AM	Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design (PR Newswire) -5.00%
Oct-29-24 08:00AM	Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya (PR Newswire)
Oct-08-24 07:00AM	Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology (PR Newswire)
Sep-30-24 07:00AM	Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals (PR Newswire) +19.92%
Aug-23-24 08:55AM	Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement (PR Newswire) +9.30%
Aug-22-24 07:00AM	Evogene Reports Second Quarter 2024 Financial Results (PR Newswire) -10.80%
Aug-12-24 07:11AM	Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule (PR Newswire) -6.74%
07:00AM	Evogene Schedules Second Quarter 2024 Financial Results Release (PR Newswire)
Jul-31-24 07:00AM	Casterra Announces the Completion of a Successful Castor Seed Growing and Harvesting Season in Brazil (PR Newswire)
Jul-23-24 08:48AM	Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split (PR Newswire) -14.60%
Jul-17-24 08:00AM	ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants (PR Newswire)
Jul-02-24 07:00AM	Lavie Bio Announces Commercial Expansion of Yalos to Winter Wheat (PR Newswire)
Jun-25-24 07:00AM	Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country (PR Newswire)
May-30-24 08:02AM	Evogene Ltd. (NASDAQ:EVGN) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-23-24 11:52AM	EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
11:00AM	Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma (PR Newswire)
07:00AM	Evogene Reports First Quarter 2024 Financial Results (PR Newswire)
May-21-24 07:03AM	Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds (PR Newswire) +5.07%
May-09-24 07:00AM	Evogene Schedules First Quarter 2024 Financial Results Release (PR Newswire)
Apr-16-24 07:00AM	Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting (PR Newswire)
Apr-11-24 07:00AM	Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting (PR Newswire)
Apr-02-24 07:00AM	Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry (PR Newswire)
Mar-28-24 09:00AM	Evogene Announces Filing of Annual Report on Form 20-F (PR Newswire)
Mar-20-24 09:00AM	Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification (PR Newswire)
Mar-19-24 09:00AM	Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing (PR Newswire)
Mar-13-24 09:00AM	Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America (PR Newswire) -5.84%
Mar-07-24 12:53PM	EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tarcic Gabi	Chief Development Officer	Jun 04 '26	Buy	0.60	1,129	677	1,129	Aug 26 04:00 PM
RECANATI LEON	Director	Aug 11 '26	Buy	0.64	460,000	292,100	1,343,886	Aug 13 07:00 AM
RECANATI LEON	Director	Aug 04 '26	Buy	0.50	800,000	400,000	883,886	Aug 05 04:07 PM

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

CEOMr. Ofer Haviv CPA

Chief Executive Officer of Casterra Ag Ltd.Mr. Yoash Zohar

Chief Executive Officer of Ag Plenus Ltd.Dr. Dan Jacob Gelvan Ph.D.

Chief Technology OfficerDr. Ilia Zhidkov

Vice President of Human ResourcesMs. Liat Foigel Wejgman

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EVGN

Evogene Ltd

Upgrade your Finviz experience